Register HERE: http://give.curepsp.org/NavigatingPSP

About the Webinar:
Join us for an engaging and informative webinar where we explore the latest breakthroughs in understanding progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).

We will cover recent advances in genetic research that have opened new insights into these challenging conditions. In this webinar, you will learn how genetic innovations are applied to study PSP, CBD and MSA and how these discoveries can pave the way for better treatments, offering hope for those affected by these complex diseases.

We will also introduce the new CurePSP Genetics Program, which seeks to uncover the genetic factors contributing to PSP, CBD and MSA.

Dr. Wills and Dr. Scholz will have time at the end to answer viewers’ questions. Submit your questions via registration or email to events@curepsp.org.

This webinar will be recorded and available on our YouTube channel following the event. We will email all registrants a link when it’s ready to view.

About the Speakers:

Anne-Marie Wills, MD, MPH:
Anne-Marie Wills MD MPH is a Neurologist specializing in neurodegenerative disease, such as Parkinson’s Disease, Progressive Supranuclear Palsy (PSP), and ALS. She received her BA from Princeton University, her MD from Columbia College Physicians & Surgeons, and her MPH from Harvard School of Public Health. She completed her specialty training in the Mass General Brigham Neurology residency program, a combined program between Massachusetts General Hospital and Brigham and Women’s Hospital. She has been on staff at Mass General since 2006.

Dr. Wills’ research focuses on environmental risk factors and determinants of neurodegenerative disease progression, including nutrition, caffeine and pesticides. Her multi-center clinical trial of nutrition in ALS (funded by the Muscular Dystrophy Association) showed that a calorically-dense diet was better tolerated and led to fewer adverse events, including deaths, than a standard diet (Wills et al. The Lancet, 2014). She is also investigating the effects of exercise interventions for neurodegenerative diseases.

She is the director of the CurePSP Center of Care at MGH which provides multidisciplinary care for people with Progressive Supranuclear Palsy. She is a member of the Movement Disorders Society, the Parkinson’s Study Group (PSG), the NorthEast ALS Consortium, and the American Academy of Neurology. She is co-director of the Genes and Environment Working Group of the PSG, co-founder of the Atypical Parkinsonian Disorders working group of the PSG and is the PI of several clinical trials in Parkinson’s disease and PSP.

Sonja Scholz, MD, PhD:
Dr. Sonja Scholz is a physician-scientist who specializes in neurodegeneration. She is a Senior Investigator and the chief of the Neurodegenerative Diseases Research Section at the National Institute of Neurological Disorders and Stroke. She is also an Adjunct Professor of Neurology at Johns Hopkins University. Her primary area of research is the genetic characterization of parkinsonism syndromes, including Lewy body dementia, multiple system atrophy, progressive supranuclear palsy, and other understudied neurodegenerative diseases. She specializes in applying modern genomic techniques and data-driven approaches to understand the genetic mechanisms underlying neurodegeneration, aiming to identify targets suitable for disease-modifying therapeutic interventions.